Understanding and Predicting “At-Risk” Generic Drug Launches: Webinar Follow-Up

[diana.papshev]

At-risk generic launches continue to create confusion among payers, providers, and patients. To review and highlight this topic, last week we held a Webinar in this area.

Highlights of How At-Risk Generics Enter the Market:

Webinar Proceedings:

Webinar proceedings are available for download EXCLUSIVELY FOR THE REGISTERED MEMBERS of DrugManagementForum and LOG-IN IS REQUIRED. If you haven't registered yet, please click here - the forum is open exclusively for those in the managed care sector (no pharma or consultants) and registration is free.

Webinar presentation AND video/audio recording - To access the proceedings, you must log in and then click here

Participant Questions and Follow-up Discussions:

We received two important questions which were not be fully addressed during the June 2010 Webinar. Over the next few weeks we would like to open the discussion on these questions to our entire community:

o Difference between At-Risk and Authorized Generics
o Credible Consumer Resources on At-Risk Generics